lot wood chop
us rx key swing factor reimburs in-lin compani expect
despit oper shortfal rel expect manag indic
facet busi came in-lin intern project except rx
growth came ss basi versu growth expect
attribut miss network exit medicaid busi summer
month less busi aetna own seen strong
perform suggest us miss volum like went
rather major market slowdown rx volum manag note
decemb one month saw solid rx growth excess full year
expect driven part flu season expect reap benefit
unh medicar plan growth well relationship relat
reimburs manag indic continu good visibl fiscal
year in-lin expect reimburs headwind
caught offguard due true-up time contract specif
seemingli expect occur similar magnitud
still see typic reimburs headwind relat calendar year flip
alreadi factor guidanc wors expect
stock beyond result manag expect bp better
tax rate prior view expect see improv core busi
trend off-set reimburs time y/i bonu impact ep
headwind lower ep given dynam
requir substanti improv vs oper trend hit
full-year guidanc investor skeptic wba abil hit target
primari reason stock weak today view all-in lower
ep ep roll
valuat basi price target still base price-to-earnings
ep
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
idc link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
equal weight walgreen continu move
reinvent busi reimburs remain
headwind compani cost cut strategi
much reflect
upsid case see better expect cost
save better gross margin core us
worsen lead multipl contract
 epsflat y/i /- y/i /- growth yr/yrflatflatadjust tax mlnrepo mlnbalanc ep across halvesbalanc ep across halvesrx growth higher growth higher dev mln expens mln higher mln expens mln higher mln capit mln higher mln capit mln higher flat eps- adj effect tax net share op barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
